Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down - Here's Why

Key Points

• Daiichi Sankyo's shares gapped down prior to trading on Monday, opening at $25.43 compared to the previous close of $26.02.
• The company's market cap is approximately $49.69 billion with a price-to-earnings ratio of 24.75, indicating its valuation in the market.
• Daiichi Sankyo manufactures various pharmaceutical products, including Enhertu, a treatment for HER2-positive breast cancer, and several other therapies targeted at specific health conditions.

Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY - )'s share price gapped down prior to trading on Monday . The stock had previously closed at $26.02, but opened at $25.43. Daiichi Sankyo shares last traded at $26.37, with a volume of 9,765 shares trading hands.

Daiichi Sankyo Trading Up 0.8%

The company has a 50 day moving average price of $24.52 and a 200 day moving average price of $24.24. The firm has a market cap of $49.69 billion and a price-to-earnings ratio of 24.75. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.60 and a current ratio of 2.31.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.